The lab collected $187 million in federal money over the course of 15 months during the COVID-19 pandemic, the report said.
The lab quickly expanded with more than 100 pop-up testing sites after starting out as a single location in a suburban strip mall. It eventually advertised sites in Kentucky, Louisiana, Florida, Wisconsin, Indiana, Minnesota, Massachusetts, California and Tennessee.
Federal inspectors found several problems during site visits, including employees who didn’t follow safety protocols. Patients complained they didn’t receive their results.
The lab director who was responsible for attesting to O’’Hare’’s safety procedures said she resigned because she had been kept in the dark about the company’’s network of pop-up locations, the report said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
